Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil

Detalhes bibliográficos
Autor(a) principal: Catalan-Soares, Bernadette
Data de Publicação: 2005
Outros Autores: Carneiro-Proietti, Anna Bárbara de F., Proietti, Fernando Augusto
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Cadernos de Saúde Pública
Texto Completo: https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2457
Resumo: Brazil may have the highest absolute number of HTLV-I/II seropositive individuals in the world. Screening potential blood donors for HTLV-I/II is mandatory in Brazil. The public blood center network accounts for about 80.0% of all blood collected. We conducted a cross-sectional study to assess the geographic distribution of HTLV-I/II serological screening prevalence rates in blood donors from 27 large urban areas in the various States of Brazil, from 1995 to 2000. Enzyme immunoassay (EIA) was used to test for HTLV-I/II. The mean prevalence rates ranged from 0.4/1,000 in Florianópolis, capital of Santa Catarina State, in the South, to 10.0/1,000 in São Luiz, Maranhão State, in the Northeast. EIA prevalence rates are lower in the South and higher in the North and Northeast. The reasons for such heterogeneity may be multiple and need further studies.
id FIOCRUZ-5_de8fca57522d1bb48fab5a9c2f6a4ef8
oai_identifier_str oai:ojs.teste-cadernos.ensp.fiocruz.br:article/2457
network_acronym_str FIOCRUZ-5
network_name_str Cadernos de Saúde Pública
repository_id_str
spelling Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in BrazilHTLV-IHTLV-IIBlood DonorsImmunoenzyme TechniquesDoadores de SangueTécnicas ImunoenzimáticasBrazil may have the highest absolute number of HTLV-I/II seropositive individuals in the world. Screening potential blood donors for HTLV-I/II is mandatory in Brazil. The public blood center network accounts for about 80.0% of all blood collected. We conducted a cross-sectional study to assess the geographic distribution of HTLV-I/II serological screening prevalence rates in blood donors from 27 large urban areas in the various States of Brazil, from 1995 to 2000. Enzyme immunoassay (EIA) was used to test for HTLV-I/II. The mean prevalence rates ranged from 0.4/1,000 in Florianópolis, capital of Santa Catarina State, in the South, to 10.0/1,000 in São Luiz, Maranhão State, in the Northeast. EIA prevalence rates are lower in the South and higher in the North and Northeast. The reasons for such heterogeneity may be multiple and need further studies.Devido ao tamanho absoluto de sua população, o Brasil pode abrigar o maior número absoluto de pessoas soropositivas para HTLV-I/II. A triagem sorológica para o HTLV-I/II, dos candidatos à doação de sangue é obrigatória no país e a rede de hemocentros é responsável pela coleta de aproximadamente 80,0% do sangue doado. Conduzimos estudo transversal para determinar e quantificar a distribuição geográfica das taxas de prevalência para HTLV-I/II resultantes da triagem em candidatos a doadores de sangue, doando em 27 áreas urbanas correspondendo às capitais de cada um dos Estados brasileiros, no período de 1995 a 2000. Neste estudo, o teste de EIA foi utilizado para testar a presença de anticorpos para HTLV-I/II. As taxas de prevalência médias apresentaram grande heterogeneidade geográfica, variando de 0,4/1.000 em Florianópolis, na Região Sul, até uma taxa 25 vezes maior, 10,0/1.000 em São Luís, na Região Nordeste. Em média, as taxas de soropositividade ao EIA são menores nas capitais do Sul do país, tendendo a aumentar em direção ao Nordeste e Norte. As razões para esta heterogeneidade podem ser múltiplas e necessitam de mais estudos.Reports in Public HealthCadernos de Saúde Pública2005-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlapplication/pdfhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2457Reports in Public Health; Vol. 21 No. 3 (2005): May/JuneCadernos de Saúde Pública; v. 21 n. 3 (2005): Maio/Junho1678-44640102-311Xreponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZenghttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2457/4922https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2457/4923Catalan-Soares, BernadetteCarneiro-Proietti, Anna Bárbara de F.Proietti, Fernando Augustoinfo:eu-repo/semantics/openAccess2024-03-06T15:27:02Zoai:ojs.teste-cadernos.ensp.fiocruz.br:article/2457Revistahttps://cadernos.ensp.fiocruz.br/ojs/index.php/csphttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/oaicadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2024-03-06T13:02:52.819385Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)true
dc.title.none.fl_str_mv Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil
title Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil
spellingShingle Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil
Catalan-Soares, Bernadette
HTLV-I
HTLV-II
Blood Donors
Immunoenzyme Techniques
Doadores de Sangue
Técnicas Imunoenzimáticas
title_short Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil
title_full Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil
title_fullStr Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil
title_full_unstemmed Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil
title_sort Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil
author Catalan-Soares, Bernadette
author_facet Catalan-Soares, Bernadette
Carneiro-Proietti, Anna Bárbara de F.
Proietti, Fernando Augusto
author_role author
author2 Carneiro-Proietti, Anna Bárbara de F.
Proietti, Fernando Augusto
author2_role author
author
dc.contributor.author.fl_str_mv Catalan-Soares, Bernadette
Carneiro-Proietti, Anna Bárbara de F.
Proietti, Fernando Augusto
dc.subject.por.fl_str_mv HTLV-I
HTLV-II
Blood Donors
Immunoenzyme Techniques
Doadores de Sangue
Técnicas Imunoenzimáticas
topic HTLV-I
HTLV-II
Blood Donors
Immunoenzyme Techniques
Doadores de Sangue
Técnicas Imunoenzimáticas
description Brazil may have the highest absolute number of HTLV-I/II seropositive individuals in the world. Screening potential blood donors for HTLV-I/II is mandatory in Brazil. The public blood center network accounts for about 80.0% of all blood collected. We conducted a cross-sectional study to assess the geographic distribution of HTLV-I/II serological screening prevalence rates in blood donors from 27 large urban areas in the various States of Brazil, from 1995 to 2000. Enzyme immunoassay (EIA) was used to test for HTLV-I/II. The mean prevalence rates ranged from 0.4/1,000 in Florianópolis, capital of Santa Catarina State, in the South, to 10.0/1,000 in São Luiz, Maranhão State, in the Northeast. EIA prevalence rates are lower in the South and higher in the North and Northeast. The reasons for such heterogeneity may be multiple and need further studies.
publishDate 2005
dc.date.none.fl_str_mv 2005-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2457
url https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2457
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2457/4922
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2457/4923
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
application/pdf
dc.publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
dc.source.none.fl_str_mv Reports in Public Health; Vol. 21 No. 3 (2005): May/June
Cadernos de Saúde Pública; v. 21 n. 3 (2005): Maio/Junho
1678-4464
0102-311X
reponame:Cadernos de Saúde Pública
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Cadernos de Saúde Pública
collection Cadernos de Saúde Pública
repository.name.fl_str_mv Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br
_version_ 1798943355056422912